Guangdong, China

Yue Yang

This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen Salubris Pharmaceuticals Co. Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue Yang. Retrieved from https://idiyas.com/inventor/yue-yang-04unnh24

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yue Yang - Innovator in Drug Application

Introduction

Yue Yang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of drug application, particularly in the development of treatment methods that utilize advanced pharmaceutical compounds. His innovative approach has led to the creation of a unique treatment method that addresses critical health issues.

Latest Patents

Yue Yang holds 1 patent for a treatment method using a complex of angiotensin II receptor antagonist metabolite and NEP inhibitor. This patent focuses on the technical field of drug application and specifically relates to the dosage of the drug, showcasing his expertise in pharmaceutical innovations.

Career Highlights

Yue Yang is currently associated with Shenzhen Salubris Pharmaceuticals Co. Ltd., where he continues to work on groundbreaking pharmaceutical solutions. His role in the company allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to drug development.

Collaborations

Yue Yang has worked alongside notable colleagues, including Lei Li and Sirao Yang. Their combined efforts in the pharmaceutical field have led to advancements in treatment methodologies and drug applications.

Conclusion

Yue Yang's innovative work in drug application exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions are paving the way for new treatment methods that can significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…